(Q38168814)

30 August 2017

Blood-based testing for colorectal cancer screening (English)

1 reference

colorectal cancer screening

30 August 2017

1 reference

1 reference

1 reference

Karen A Heichman

1

1 reference

30 August 2017

1 April 2014

1 reference

Molecular Diagnosis and Therapy

30 August 2017

1 reference

30 August 2017

18

1 reference

30 August 2017

2

1 reference

30 August 2017

127-135

1 reference

https://scigraph.springernature.com/pub.10.1007/s40291-013-0074-z

30 August 2017

0 references

cites work

Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007.

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Patterns of colorectal cancer screening uptake among men and women in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

CT colonography may improve colorectal cancer screening compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Preferences for blood-based colon cancer screening differ by race/ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Novel blood-based, five-gene biomarker set for the detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

DNA methylation biomarkers for blood-based colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Randomised controlled trial of faecal-occult-blood screening for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Randomised study of screening for colorectal cancer with faecal-occult-blood test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Polypectomy of adenomas in the prevention of colorectal cancer: 10 years' follow-up of the Telemark Polyp Study I. A prospective, controlled population study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

A Case–Control Study of Screening Sigmoidoscopy and Mortality from Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Systematic review and meta-analysis of the evidence for flexible sigmoidoscopy as a screening method for the prevention of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Clinicopathologic significance of KIAA1199 overexpression in human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Unraveling the role of KIAA1199, a novel endoplasmic reticulum protein, in cancer cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Comparative study of carcinoembryonic antigen and epithelial membrane antigen expression in normal colon, adenomas and adenocarcinomas of the colon and rectum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

The influence of methylated septin 9 gene on RNA and protein level in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-013-0074-Z

Protection by endoscopy against death from colorectal cancer. A case-control study among veterans

21 January 2018

1 reference

12 December 2020

Long-Term Efficacy of Sigmoidoscopy in the Reduction of Colorectal Cancer Incidence

1 reference

12 December 2020

Cancer. Developing molecular biomarkers for cancer

1 reference

12 December 2020

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer

1 reference

12 December 2020

A case-controlled validation study of a blood-based seven-gene biomarker panel for colorectal cancer in Malaysia

1 reference

12 December 2020

Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?

1 reference

12 December 2020

Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"--SCORE

1 reference

12 December 2020

A blood-based biomarker panel for stratifying current risk for colorectal cancer.

1 reference

12 December 2020

Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis

1 reference

12 December 2020

Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing

1 reference

12 December 2020

Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study

1 reference

12 December 2020

Plasma miR-21: a potential diagnostic marker of colorectal cancer

1 reference

12 December 2020

Quantitative assessment of bowel wall vascularisation in Crohn's disease with contrast-enhanced ultrasound and perfusion analysis

1 reference

12 December 2020

Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer

1 reference

12 December 2020

A multiplex serum protein assay for determining the probability of colorectal cancer

1 reference

12 December 2020

Loss of IGF2 imprinting: a potential marker of colorectal cancer risk

1 reference

12 December 2020

10.1007/S40291-013-0074-Z

Identifiers

DOI

1 reference

PubMed ID

24307563

Dimensions Publication ID

30 August 2017

1024641646

0 references

Fatcat ID

release_dkbj6r7zgnay7inkkukn7e55we

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dkbj6r7zgnay7inkkukn7e55we

24 November 2022

mapped directly with Wikidata item

PubMed ID

24307563

1 reference

PubMed ID

24307563